🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 7

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 7 of 9
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jun 11, 2025 at 3:35 PM#31

Adding the numbers, since they settle part of this. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

That is the short version; the long version is somebody else's post.

11 9JakeSmashed95, NauseaFreeNow, SteveThurs and 8 others
Reply Quote Save Share Report
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Jun 12, 2025 at 1:52 AM#32

One thing that is still open after andrew_nyc’s answer:

How would you tell the difference between that and the alternative explanation?

12 10JessicaM_2024, TomFromTexas, mike.trainer_LA and 9 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jun 12, 2025 at 12:09 PM#33
Dr.NateNeph said:
One practical note: write down what you did and when, before you need it.

This is where I part company with the consensus forming above. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

13 11lori_vegas, Dr.PulmRoch, maya_sedona and 10 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
denise_HTX
Member
145
678
Jan 2025
Houston, TX
Jun 12, 2025 at 10:26 PM#34
Dr.NateNeph said:
One practical note: write down what you did and when, before you need it.

True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.

Happy to go further on any of that.

14 12KevinCompounds, TirzTom, TrialTracker_MD and 11 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Jun 13, 2025 at 8:42 AM#35
Dr.NateNeph said:
One practical note: write down what you did and when, before you need it.

Thank you for spelling out the reasoning rather than just the conclusion.

15 13LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 12 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register